These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 39178066)
1. CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage. Ziccardi S; Tamanti A; Ruggieri C; Guandalini M; Marastoni D; Camera V; Montibeller L; Mazziotti V; Rossi S; Calderone M; Pizzini FB; Montemezzi S; Magliozzi R; Calabrese M Neurol Neuroimmunol Neuroinflamm; 2024 Nov; 11(6):e200301. PubMed ID: 39178066 [TBL] [Abstract][Full Text] [Related]
2. CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis. Magliozzi R; Pitteri M; Ziccardi S; Pisani AI; Montibeller L; Marastoni D; Rossi S; Mazziotti V; Guandalini M; Dapor C; Schiavi G; Tamanti A; Nicholas R; Reynolds R; Calabrese M Ann Clin Transl Neurol; 2021 Mar; 8(3):534-547. PubMed ID: 33484486 [TBL] [Abstract][Full Text] [Related]
3. [A study of the correlation between gray matter atrophy in multiple sclerosis and impairment of cognitive function domains]. Han J; Wang QJ; Wang CH; Li ZH; Bai RH; Zhang X; Liu JG Zhonghua Nei Ke Za Zhi; 2024 Jul; 63(7):666-673. PubMed ID: 38951090 [No Abstract] [Full Text] [Related]
4. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis. Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581 [TBL] [Abstract][Full Text] [Related]
9. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study. Preziosa P; Pagani E; Mesaros S; Riccitelli GC; Dackovic J; Drulovic J; Filippi M; Rocca MA Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103 [TBL] [Abstract][Full Text] [Related]
10. Relationship between Social Cognition and traditional cognitive impairment in Progressive Multiple Sclerosis and possible implicated neuroanatomical regions. Ciampi E; Uribe-San-Martin R; Vásquez M; Ruiz-Tagle A; Labbe T; Cruz JP; Lillo P; Slachevsky A; Reyes D; Reyes A; Cárcamo-Rodríguez C Mult Scler Relat Disord; 2018 Feb; 20():122-128. PubMed ID: 29414284 [TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery. Pellicano C; Kane RL; Gallo A; Xiaobai L; Stern SK; Ikonomidou VN; Evangelou IE; Ohayon JM; Ehrmantraut M; Cantor FK; Bagnato F J Neuroimaging; 2013 Jul; 23(3):445-52. PubMed ID: 23227967 [TBL] [Abstract][Full Text] [Related]
12. Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study. Ziccardi S; Pisani AI; Schiavi GM; Guandalini M; Crescenzo F; Colombi A; Peloso A; Tamanti A; Bertolazzo M; Marastoni D; Calabrese M Eur J Neurol; 2023 May; 30(5):1378-1388. PubMed ID: 36692863 [TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis. Tortorella C; Direnzo V; Ruggieri M; Zoccolella S; Mastrapasqua M; D'Onghia M; Paolicelli D; Cuonzo FD; Gasperini C; Trojano M Mult Scler; 2018 Jul; 24(8):1039-1045. PubMed ID: 28537100 [TBL] [Abstract][Full Text] [Related]
15. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis. Xiang B; Wen J; Cross AH; Yablonskiy DA J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934 [TBL] [Abstract][Full Text] [Related]
16. Distinct Patterns of Brain Atrophy associated with Mild Behavioral Impairment in Cognitively Normal Elderly Adults. Shu J; Qiang Q; Yan Y; Wen Y; Ren Y; Wei W; Zhang L Int J Med Sci; 2021; 18(13):2950-2956. PubMed ID: 34220322 [TBL] [Abstract][Full Text] [Related]
17. The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome. Diker S; Has AC; Kurne A; Göçmen R; Oğuz KK; Karabudak R Mult Scler Relat Disord; 2016 Nov; 10():14-21. PubMed ID: 27919482 [TBL] [Abstract][Full Text] [Related]
18. The impact of deep grey matter volume on cognition in multiple sclerosis. Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200 [TBL] [Abstract][Full Text] [Related]
19. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort. Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051 [TBL] [Abstract][Full Text] [Related]
20. Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis. Pérez-Miralles FC; Prefasi D; García-Merino A; Ara JR; Izquierdo G; Meca-Lallana V; Gascón-Giménez F; Martínez-Ginés ML; Ramió-Torrentà L; Costa-Frossard L; Fernández Ó; Moreno-García S; Maurino J; Carreres-Polo J; Casanova B Brain Behav; 2021 Apr; 11(4):e02044. PubMed ID: 33486890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]